Trials / Completed
CompletedNCT01548417
Medication Development in Alcoholism: Investigating Glucocorticoid Antagonists
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 56 (actual)
- Sponsor
- The Scripps Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The primary hypotheses under test are that alcohol dependent subjects treated with mifepristone will report decreased craving for alcohol following alcohol exposure in the laboratory and report significantly less drinking under naturalistic conditions, than those treated with placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Korlym (mifepristone) | 600 mg/day, oral pill, 7 days |
| DRUG | Sugar Pill | 600 mg/day, oral pill, 7 days |
Timeline
- Start date
- 2012-03-01
- Primary completion
- 2015-07-01
- Completion
- 2015-07-01
- First posted
- 2012-03-08
- Last updated
- 2016-06-24
- Results posted
- 2016-05-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01548417. Inclusion in this directory is not an endorsement.